4.4 Review

Deliquescence of pharmaceutical systems

期刊

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
卷 15, 期 6, 页码 582-594

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/10837450903397594

关键词

Deliquescence; hygroscopicity; chemical stability; physical stability; powder blends

资金

  1. AstraZeneca RD Lund
  2. Dane O'Kildsig Center for Pharmaceutical Processing Research
  3. American Foundation for Pharmaceutical Education
  4. USDA-NRICGP [07-35505-18405]

向作者/读者索取更多资源

Deliquescence is a first order phase transition from solid to solution that occurs at a relative humidity (RH) that is characteristic to the crystalline compound. Such dissolution of active pharmaceutical ingredients and excipients can lead to detrimental physical and chemical instabilities. Furthermore, in systems containing more than one deliquescent component, the RH of the solid-solution transition will be lowered, leading to some level of dissolution at unexpectedly low RH conditions. Deliquescence lowering is independent of the ratio of the deliquescent components and therefore is of concern for any formulation containing two or more deliquescent compounds. Because chemical reactions occur much more readily in solution, deliquescence will enhance the degradation of labile APIs. RH fluctuations will lead to cycles of deliquescence and efflorescence (crystallization), which will contribute to particle agglomeration and caking. This review will address the phenomenon of deliquescence, the significance of deliquescence to pharmaceutical systems, measurement techniques, the kinetics and thermodynamics of deliquescence, the behavior of mixtures of deliquescent compounds (including phase diagrams and thermodynamics of binary systems), and consequences of deliquescence on chemical and physical stability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据